FDA Inspection
OneBlood; IncOneBlood; Inc – FDA Inspection, Mar 12, 2020
Record Details
This FDA Inspection record concerns OneBlood; Inc, with an inspection on March 12, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood; Inc
- Inspection Date
- March 12, 2020
- Product Type
- Biologics
View Company Profile
ID · a69654d8-fe35-4ba1-b9aa-7466e5984f94
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1121336
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of OneBlood; Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 27, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 13, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 3, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 9, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood; Inc
- FDA Inspection 1325374 - 2026-06-23
- FDA Inspection 1048694 - 2018-03-27
- FDA Inspection 974161 - 2016-06-13
- FDA Inspection 858272 - 2013-12-03
- FDA Inspection 753410 - 2011-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.